Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FKEFZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,234
Award facts
- Contract value 100% obligated
- $8,234.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8,234.32 by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. The award, issued on May 20, 2025, with an ultimate completion date of June 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for prolonged local anesthesia and pain management in surgical and medical settings, making it a critical pharmaceutical supply for Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.99 billion blanket agreement valid through November 2026. The IDC establishes the company as a key supplier for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, enabling the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables. The company's consistent federal contract performance and woman-owned small business status have positioned it as a crucial distributor in the federal pharmaceutical supply chain serving Defense Department healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKEFZ?
SPE2DB25FKEFZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FKEFZ worth?
The government has obligated $8,234 on SPE2DB25FKEFZ.
Is contract SPE2DB25FKEFZ an order under another contract?
Yes. SPE2DB25FKEFZ is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEFZ competed?
The extent of competition for SPE2DB25FKEFZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award